<?xml version="1.0" encoding="UTF-8"?>
<fig id="genes-12-00257-f002" orientation="portrait" position="float">
 <label>Figure 2</label>
 <caption>
  <p>Enrichment of CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3 gene set in LNCaP CNTN1 cells. (
   <bold>A</bold>) Gene set enrichment analysis (GSEA) analysis reveals the enrichment of CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3 gene set in the differentially expressed genes (DEGs) relative to CNTN1 overexpression (LNCaP CNTN1 vs. LNCaP EV). The leading-edge genes (
   <italic>n</italic> = 10) in this enrichment are indicated (see 
   <xref rid="genes-12-00257-t001" ref-type="table">Table 1</xref> for individual leading-edge genes). (
   <bold>B</bold>) Confirmation of the upregulations of 7 of 10 leading-edge genes in LNCaP CNTN1 cells. (
   <bold>C</bold>) Confirmation of CNTN1 overexpression in LNCaP CNTN1 cells. * 
   <italic>p</italic> &lt; 0.05, ** 
   <italic>p</italic> &lt; 0.01, *** 
   <italic>p</italic> &lt; 0.001, **** 
   <italic>p</italic> &lt; 0.0001.
  </p>
 </caption>
 <graphic xlink:href="genes-12-00257-g002" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
